- ICH GCP
- US Clinical Trials Registry
- Search trials
Clinical Trials on Benign Prostatic Hyperplasia in United Kingdom
Total 4559 results
-
University of Southern CaliforniaNational Cancer Institute (NCI); AEterna ZentarisCompletedRecurrent Prostate Cancer | Prostate Cancer | Hormone-resistant Prostate Cancer | Stage IV Prostate CancerUnited States
-
University of Southern CaliforniaNational Cancer Institute (NCI)UnknownRecurrent Prostate Cancer | Hormone-resistant Prostate Cancer | Stage IV Prostate CancerUnited States
-
Jeanne LinkOregon Health and Science University; OHSU Knight Cancer Institute; OHSU Center...Approved for marketingProstatic Neoplasms | Prostatic Diseases | Prostate Cancer | Prostate Cancer Recurrent | Prostate Cancer MetastaticUnited States
-
University of ChicagoNational Cancer Institute (NCI)CompletedCastration-resistant Prostate Cancer | Stage IV Prostate CancerSingapore, United States
-
University of California, IrvineCompletedRecurrent Prostate Cancer | Stage I Prostate Cancer | Stage III Prostate Cancer | Adenocarcinoma of the Prostate | Stage IIA Prostate Cancer | Stage IIB Prostate CancerUnited States
-
M.D. Anderson Cancer CenterCelgeneCompleted
-
University of California, IrvineWithdrawnProstate LesionsUnited States
-
Albert DeNittisUnknown
-
Genzyme, a Sanofi CompanyCompletedProstate Cancer | Prostate AdenocarcinomaUnited States
-
University of California, San FranciscoCompletedMetastatic Prostate CancerUnited States
-
University of Michigan Rogel Cancer CenterExelixisTerminatedProstate Cancer MetastaticUnited States
-
Cougar Biotechnology, Inc.CompletedProstate Cancer | Prostate NeoplasmsUnited States
-
Orion Corporation, Orion PharmaEndo PharmaceuticalsCompletedProstate CancerUnited States, United Kingdom, Finland, France, Czech Republic, Estonia
-
Lightpoint Medical LimitedUniversity College London Hospitals; University College, LondonCompleted
-
Cougar Biotechnology, Inc.CompletedProstatic NeoplasmsUnited Kingdom
-
Rutgers, The State University of New JerseyNational Cancer Institute (NCI); Rutgers Cancer Institute of New JerseyTerminatedRecurrent Prostate Carcinoma | Stage I Prostate Cancer | Stage III Prostate Cancer | Stage IIA Prostate Cancer | Stage IIB Prostate CancerUnited States
-
National Cancer Institute (NCI)CompletedRecurrent Prostate Cancer | Adenocarcinoma of the Prostate | Stage IV Prostate CancerUnited States
-
ORIC PharmaceuticalsRecruitingMetastatic Prostate Cancer | Neuroendocrine Prostate CancerUnited States
-
Northwestern UniversityNorthShore University HealthSystemCompletedProstate CancerUnited States
-
University of MiamiCompletedProstate Cancer | Prostate Adenocarcinoma | Radiation ToxicityUnited States
-
Donald Trump, MDTerminated
-
Burzynski Research InstituteWithdrawnStage IV Prostate CancerUnited States
-
Temple UniversityCompleted
-
Veeda OncologyBayerTerminatedHormone Refractory Prostate CancerUnited States
-
University of FloridaCureVacTerminated
-
CytRxCompletedHormone Refractory Prostate CancerUnited States
-
Sidney Kimmel Comprehensive Cancer Center at Johns...Bristol-Myers SquibbCompletedProstate Cancer | Recurrent Prostate Carcinoma | Stage IV Prostate AdenocarcinomaUnited States
-
Jonsson Comprehensive Cancer CenterCompletedProstate Adenocarcinoma | Stage IV Prostate Cancer AJCC v7 | Stage III Prostate Cancer AJCC v7 | Stage IIB Prostate Cancer AJCC v7United States
-
Barbara Ann Karmanos Cancer InstituteNational Cancer Institute (NCI)CompletedRecurrent Prostate Cancer | Hormone-resistant Prostate Cancer | Adenocarcinoma of the Prostate | Stage IV Prostate CancerUnited States
-
University College, LondonRecruitingUrinary Incontinence | Prostate Cancer | Male Erectile Disorder | Therapy-related ToxicityUnited Kingdom
-
Zin W MyintCompletedProstate Cancer | Prostate Adenocarcinoma | Prostate Cancer RecurrentUnited States
-
Advocate Health CareRecruitingProstate AdenocarcinomaUnited States
-
GenSpera, Inc.WithdrawnProstate Cancer.United States
-
University of Southern CaliforniaNational Cancer Institute (NCI)CompletedAdenocarcinoma of the Prostate | Stage IIA Prostate Cancer | Stage IIB Prostate CancerUnited States
-
OHSU Knight Cancer InstituteBristol-Myers Squibb; Oregon Health and Science UniversityCompletedRecurrent Prostate Cancer | Hormone-resistant Prostate Cancer | Adenocarcinoma of the Prostate | Stage IV Prostate CancerUnited States
-
National Cancer Institute (NCI)CompletedRecurrent Prostate Cancer | Stage I Prostate Cancer | Adenocarcinoma of the Prostate | Stage IIA Prostate Cancer | Stage IIB Prostate CancerUnited States
-
Royal Marsden NHS Foundation TrustMerck Sharp & Dohme LLC; Astex Pharmaceuticals, Inc.; Institute of Cancer Research...RecruitingNon Small Cell Lung Cancer | Castration-Resistant Prostatic CancerUnited Kingdom
-
The Methodist Hospital Research InstituteRecruitingProstate Cancer | High-risk Prostate CancerUnited States
-
Dana-Farber Cancer InstituteMedivation, Inc.Completed
-
Sidney Kimmel Comprehensive Cancer Center at Johns...National Cancer Institute (NCI)CompletedStage IV Prostate CancerUnited States
-
OHSU Knight Cancer InstitutePfizerTerminatedProstate Cancer | Adenocarcinoma of the ProstateUnited States
-
Sidney Kimmel Comprehensive Cancer Center at Johns...Johns Hopkins UniversityCompletedSuspected Primary Prostate CancerUnited States
-
Massachusetts General HospitalDana-Farber Cancer InstituteCompletedProstate Cancer | Adenocarcinoma of the ProstateUnited States
-
Virginia Commonwealth UniversityWithdrawnProstate CancerUnited States
-
European Organisation for Research and Treatment...CompletedProstate CancerBelgium, Poland, Italy, Austria, France, Denmark, Netherlands, United Kingdom, Israel, Spain, Portugal
-
Daniel VaenaCompletedProstate Cancer | Castrate Resistant Prostate CancerUnited States
-
Rutgers, The State University of New JerseyNational Cancer Institute (NCI); Rutgers Cancer Institute of New JerseyCompletedMetastatic Prostate Carcinoma | Metastatic Prostatic Adenocarcinoma | Prostate Carcinoma Metastatic to the BoneUnited States
-
University of WashingtonNational Cancer Institute (NCI); Prostate Cancer FoundationTerminatedRecurrent Prostate Cancer | Castration-resistant Prostate Cancer | Stage III Prostate Cancer | Adenocarcinoma of the Prostate | Stage IV Prostate CancerUnited States
-
John P. FruehaufSanofiTerminatedRecurrent Prostate Cancer | Prostate Cancer | Stage I Prostate Cancer | Stage III Prostate Cancer | Adenocarcinoma of the Prostate | Stage IV Prostate CancerUnited States
-
Massachusetts General HospitalBayerCompletedProstate Cancer | Castration-resistant Prostate Cancer | Castration-resistant Prostate Cancer Metastatic to BoneUnited States